UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study

Gastroenterology (New York, N.Y. 1943), 2005, Vol.128 (7), p.1805-1811

2005

Volltextzugriff (PDF)

The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection

PloS one, 2015-08, Vol.10 (8), p.e0120866-e0120866

2015

Volltextzugriff (PDF)

A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C—Associated Liver Cirrhosis

Clinical infectious diseases, 2013-07, Vol.57 (2), p.230-236

2013

Volltextzugriff (PDF)

Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection

European journal of gastroenterology & hepatology, 2005-11, Vol.17 (11), p.1153-1155

2005

Volltextzugriff (PDF)

Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study

Alimentary pharmacology & therapeutics, 2010-10, Vol.32 (8), p.984-989

2010

Volltextzugriff (PDF)

IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection

Hepatology (Baltimore, Md.), 2011-03, Vol.53 (3), p.746-754

2011

Volltextzugriff (PDF)

Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis

Scandinavian journal of gastroenterology, 2017-01, Vol.52 (9), p.1022-1028

2017

Volltextzugriff (PDF)

Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine

Digestive and liver disease, 2019-02, Vol.51 (2), p.253-257

2019

Volltextzugriff (PDF)

Acute renal failure is a common complication in liver cirrhosis

Läkartidningen, 2016-03, Vol.113

2016

Volltextzugriff (PDF)

High sustained response rate in patients with histologically mild (low grade and stage) chronic hepatitis C infection. A randomized, double blind, placebo controlled trial of interferon alpha-2b with and without ribavirin

European journal of gastroenterology & hepatology, 2002-06, Vol.14 (6), p.627-633

2002

Volltextzugriff (PDF)

Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis

Medicine (Baltimore), 2017-08, Vol.96 (34)

2017

Volltextzugriff (PDF)

Increased hope following successful treatment for hepatitis C infection

Journal of advanced nursing, 2018-03, Vol.74 (3), p.724-733

2018

Volltextzugriff (PDF)

Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis - a long-term follow-up study in 634 Swedish patients

Scandinavian journal of gastroenterology, 2015-02, Vol.50 (2), p.217-223

2015

Volltextzugriff (PDF)

Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

Hepatology (Baltimore, Md.), 2008-01, Vol.47 (1), p.35-42

2008

Volltextzugriff (PDF)

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid‐refractory ulcerative colitis: A retrospective observational study

Inflammatory bowel diseases, 2012-02, Vol.18 (2), p.212-218

2012

Volltextzugriff (PDF)

Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016

Infectious diseases (London, England), 2017-08, Vol.49 (8), p.561-575

2017

Volltextzugriff (PDF)

Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis

Journal of hepatology, 2010-01, Vol.52 (1), p.106-111

2010

Volltextzugriff (PDF)

Peg-IFN and ribavirin treatment for recurrence of genotype 2 and 3 hepatitis C after liver transplantation

Infectious diseases (London, England), 2015, Vol.47 (4), p.209-217

2015

Volltextzugriff (PDF)

In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks. Pooled analysis of two Scandinavian trials

European journal of gastroenterology & hepatology, 2010-05, Vol.22 (5), p.552-556

2010

Volltextzugriff (PDF)

Dynamic FDG‐PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation

Hepatology (Baltimore, Md.), 2006-12, Vol.44 (6), p.1572-1580

2006

Volltextzugriff (PDF)

Health-related quality of life in patients with different stages of liver disease induced by hepatitis C

Scandinavian journal of gastroenterology, 2009, Vol.44 (7), p.878-887

2009

Volltextzugriff (PDF)

Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations

Infectious diseases (London, England), 2016-04, Vol.48 (4), p.251-261

2016

Volltextzugriff (PDF)

The clinical importance in differentiating portal from mesenteric venous thrombosis

International angiology, 2011-02, Vol.30 (1), p.71

2011

Volltextzugriff (PDF)

Prevalence of hepatitis C in Swedish diabetics is low and comparable to that in health care workers

European journal of gastroenterology & hepatology, 2008-02, Vol.20 (2), p.135-138

2008

Volltextzugriff (PDF)

The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection: e0120866

PloS one, 2015-08, Vol.10 (8)

2015

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(59)
Schwedisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(42)
Science & Technology
(42)
Life Sciences & Biomedicine
(41)
Medicin Och Hälsovetenskap
(40)
Clinical Medicine
(36)
Klinisk Medicin
(36)
Medical And Health Sciences
(35)
Female
(32)
Male
(32)
Middle Aged
(31)
Gastroenterologi
(28)
Gastroenterology And Hepatology
(27)
Adult
(26)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Gastroenterology & Hepatology
(22)
Aged
(20)
Infectious Diseases
(19)
Gastroenterology. Liver. Pancreas. Abdomen
(13)
Hepatitis C
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study

The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection

A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C—Associated Liver Cirrhosis

Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection

Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study

IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection

Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis

Mycophenolate mofetil treatment in patients with autoimmune hepatitis failing standard therapy with prednisolone and azathioprine

Acute renal failure is a common complication in liver cirrhosis

High sustained response rate in patients with histologically mild (low grade and stage) chronic hepatitis C infection. A randomized, double blind, placebo controlled trial of interferon alpha-2b with and without ribavirin

Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis

Increased hope following successful treatment for hepatitis C infection

Hepatocellular and extrahepatic cancer in patients with autoimmune hepatitis - a long-term follow-up study in 634 Swedish patients

Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid‐refractory ulcerative colitis: A retrospective observational study

Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016

Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis

Peg-IFN and ribavirin treatment for recurrence of genotype 2 and 3 hepatitis C after liver transplantation

In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks. Pooled analysis of two Scandinavian trials

Dynamic FDG‐PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation

Health-related quality of life in patients with different stages of liver disease induced by hepatitis C

Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations

The clinical importance in differentiating portal from mesenteric venous thrombosis

Prevalence of hepatitis C in Swedish diabetics is low and comparable to that in health care workers

The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection: e0120866

Suchergebnisse filtern